1 Min Read
Sept 11 (Reuters) - Glenmark Pharmaceuticals
* Says co receives ANDA approval for propafenone hydrochloride extended-release capsules USP, 225 mg, 325 mg, and 425 mg Source text - bit.ly/2ePWYfs Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.